Thus, it is likely that targeting MTA1 and MTA1-associated molecular and cellular events by dietary pterostilbene in the high-risk population and patients with early stages of prostate cancer, i.e. patients on active surveillance with deregulated MTA1, could be the most needed immediate chemopreventive strategy. The gene discussed is MTA1; the disease is prostate cancer.